Intrathecal Hydrocortisone in the Treatment of Tuberculous Meningitis (Preliminary Report)

  • Harsoyo N. Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
  • Moeljono S. Trastotenojo Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
  • Soejono Soejono Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
  • Dedy Abubakar Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
  • Indra Warman Department of Child Health, Universitas Diponegoro Medical School/Dr. Kariadi Hospital, Semarang, Central Java
DOI: https://doi.org/10.14238/pi16.9-10.1976.355-60
Keywords: intrathecal hydrocortisone; tuberculous meningitis; optic nerve atrophy;

Abstract

A trial on the treatment of tuberculous meningitis with intrathecal hydrocortisone, beside INH, PAS, and Streptomycin, performed at the Dr. Kariadi General Hospital in October 1972, is reported. Eighteen patients were treated, giving good results; 5.6% mortality were noted. A great number of complications

of optic nerve atrophy (61.1 %) were found and 22.2% with early atrophy recovered. The results are better compared with those of Choremis et al. (1957) who found a mortality of 13.7% among 29 patients with tuberculous meningitis treated in the same way, except P.A.S.

Published
2019-09-17
How to Cite
1.
N. H, Trastotenojo M, Soejono S, Abubakar D, Warman I. Intrathecal Hydrocortisone in the Treatment of Tuberculous Meningitis (Preliminary Report). PI [Internet]. 17Sep.2019 [cited 13Nov.2024];16(9-10):355-0. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2310
Issue
Vol 16 No 9-10 (1976): September - October 1976
Section
Infection & Tropical Pediatrics

Copyright (c) 2019 Harsoyo N., Moeljono S. Trastotenojo, Soejono Soejono, Dedy Abubakar, Indra Warman

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Received 2019-09-17
Published 2019-09-17